Construction of epidithiodioxopiperazines by directed oxidation of hydroxyproline-derived dioxopiperazines

Organic Letters

Volumn 9, Issue 25, 2007, Pages 5267-5270

  Overman, Larry E ^a   Sato, Takaaki ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; ETHER; HYDROXYPROLINE; OXYGEN; PIPERAZINE DERIVATIVE; THIOL DERIVATIVE; TRYPTOPHAN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; OXIDATION REDUCTION REACTION; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

BIOLOGICAL PRODUCTS; CRYSTALLOGRAPHY, X-RAY; ETHER, ETHYL; HYDROXYPROLINE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; OXYGEN; PIPERAZINES; SULFHYDRYL COMPOUNDS; TRYPTOPHAN;

EID: 37249068440     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol702518t     Document Type: Article

References (54)

1. For reviews, see: (a) Waring, P.; Eichner, R. D.; Müllbacher, A. Med. Res. Rev. 1988, 8, 499-524.
2. (b) Gardiner, D. M.; Waring, P.; Howlett, B. J. Microbiology 2005, 151, 1021-1032.
3. Takahashi, C.; Numata, A.; Ito, Y.; Matsumura, E.; Araki, H.; Iwaki, H.; Kushida, K. J. Chem. Soc., Perkin Trans. 1 1994, 1859-1864.
4. Takahashi, C.; Minoura, K.; Yamada, T.; Numata, A.; Kushida, K.; Shingu, T.; Hagishita, S.; Nakai, H.; Sato, T.; Harada, H. Tetrahedron 1995, 51, 3483-3498.
5. (a) Trown, P. W. Biochem. Biophys. Res. Commun. 1968, 33, 402-407.
6. (b) Hino, T.; Sato, T. Tetrahedron Lett. 1971, 12, 3127-3129.
7. (c) Öhler, E.; Poisel, H.; Tataruch, F.; Schmidt, U. Chem. Ber. 1972, 105, 635-641.
8. (d) Öhler, E.; Tataruch, F.; Schmidt, U. Chem. Ber. 1973, 106, 165-176.
9. (e) Yoshimura, J.; Nakamura, H.; Matsunari, K.; Sugiyama, Y. Chem. Lett. 1974, 559-560.
10. (f) Kishi, Y.; Fukuyama, T.; Nakatsuka, S. J. Am. Chem. Soc. 1973, 95, 6490-6492.
11. (g) Kishi, Y.; Fukuyama, T.; Nakatsuka, S. J. Am. Chem. Soc. 1973, 95, 6492-6493.
12. (h) Kishi, Y.; Nakatsuka, S.; Fukuyama, T.; Havel, M. J. Am. Chem. Soc. 1973, 95, 6493-6495.
13. (i) Fukuyama, T.; Nakatsuka, S.; Kishi, Y. Tetrahedron 1981, 37, 2045-2078.
14. (j) Strunz, G. M.; Kakushima, M. Experientia 1974, 30, 719-720.
15. (k) Ottenheijm, H. C. J.; Herscheid, J. D. M.; Kerkhoff, G. P. C.; Spande, T. F. J. Org. Chem. 1976, 41, 3433-3438.
16. (l) Herscheid, J. D. M.; Nivard, R. J. F.; Tijhuis, M. W.; Ottenheijm, H. C. J. J. Org. Chem. 1980, 45, 1885-1888.
17. (m) Williams, R. M.; Rastetter, W. H. J. Org. Chem. 1980, 45, 2625-2631.
18. (n) Srinivasan, A.; Kolar, A. J.; Olsen, R. K. J. Heterocycl. Chem. 1981, 18, 1545-1548.
19. (o) Shimazaki, N.; Shima, I.; Hemmi, K.; Tsurumi, Y.; Hashimoto, M. Chem. Pharm. Bull. 1987, 35, 3527-3530.
20. (p) Jiang, H.; Newcombe, N.; Sutton, P.; Lin, Q. H.; Müllbacher, A.; Waring, P. Aust. J. Chem. 1993, 46, 1743-1754.
21. (q) Wu, Z.; Williams, L. J.; Danishefsky, S. J. Angew. Chem., Int. Ed. 2000, 39, 3866-3868.
22. (r) Aliev, A. E.; Hilton, S. T.; Motherwell, W. B.; Selwood, D. L. Tetrahedron Lett. 2006, 47, 2387-2390.
23. For synthetic studies toward cyclotryptophan-containing ETPs by other groups, see: (a) Crich, D.; Fredette, E.; Flosi, W. J. Heterocycles 1998, 48, 545-547.
24. (b) Yamada, F.; Goto, A.; Somei, M. Heterocycles 2000, 53, 1255-1258.
25. For the recent total synthesis of a related, structurally simpler cyclotryptophan alkaloid, see: Overman, L. E.; Shin, Y. Org. Lett. 2007, 9, 339-341.
26. For an early example of 1,5-radical translocation from a protecting group, see: Curran, D. P.; Kim, D.; Liu, H. T.; Shen, W. J. Am. Chem. Soc. 1988, 110, 5900-5902.
27. For examples of C-H bond oxidation α to oxygen of alcohol derivatives, see: (a) Lewin, A. H.; Dinwoodie, A. H.; Cohen, T. Tetrahedron 1966, 22, 1527-1537.
28. (b) Curran, D. P.; Yu, H. Synthesis 1992, 123-127.
29. (c) Han, G.; Mcintosh, M. C.; Weinreb, S. M. Tetrahedron Lett. 1994, 35, 5813-5816.
30. For examples of C-H bond oxidation δ to oxygen of alcohol derivatives, see: (a) Barton, D. H. R.; Beaton, J. M.; Geller, L. E.; Pechet, M. M. J. Am. Chem. Soc. 1960, 82, 2640-2641.
31. For recent reviews, see: (b) Majetich, G.; Wheless, K. Tetrahedron 1995, 51, 7095-7129.
32. (c) Reese, P. B. Steroids 2001, 66, 481-497.
33. (d) Togo, H.; Katohgi, M. Synlett 2001, 565-581.
34. (e) Čeković, Ž. Tetrahedron 2003, 59, 8073-8090.
35. Intramolecular hydrogen atom abstraction β to a protected alcohol, followed by C-C bond formation or trapping with hydrogen has been described; see: (a) Brunckova, J.; Crich, D.; Yao, Q. Tetrahedron Lett. 1994, 35, 6619-6622.
36. (b) Yamazaki, N.; Eichenberger, E.; Curran, D. P. Tetrahedron Lett. 1994, 35, 6623-6626.
37. (c) Curran, D. P.; Xu, J. J. Am. Chem. Soc. 1996, 118, 3142-3147.
38. (d) Moenius, T.; Andres, H.; Acemoglu, M.; Kohler, B.; Schnelli, P.; Zueger, C. J. Labelled Compd. Radiopharm. 2000, 43, 113-120.
39. (e) Sukeda, M.; Matsuda, A.; Shuto, S. Tetrahedron 2005, 61, 7865-7873.
40. (f) Sakaguchi, N.; Hirano, S.; Matsuda, A.; Shuto, S. Org. Lett. 2006, 8, 3291-3294.
41. Synthesis of 3-hydroxyproline derivative 6 is described in the Supporting Information.
42. Parikh, J. R.; Doering, W. E. J. Am. Chem. Soc. 1967, 89, 5505-5507.
43. Attempted cleavage of the TBS group under several other conditions (TBAF, HF/pyridine, or MeOH in HCl) led to significant decomposition.
44. For pioneering studies of the use of (bromomethyl)dimethylsiloxy ethers in free radical chain reactions, see: (a) Nishiyama, H.; Kitajima, T.; Matsumoto, M.; Itoh, K. J. Org. Chem. 1984, 49, 2298-2300.
45. (b) Stork, G.; Kahn, M. J. Am. Chem. Soc. 1985, 107, 500-501.
46. The synthesis of α-bromomethylsilyl 13 is described in the Supporting Information.
47. In an early calibration experiment, the reaction of iodoacetal i with tributyltin hydride, AIBN, and TEMPO in benzene at 85°C resulted only in substitution at the acetal substituent to provide TEMPO adduct ii. This result showed that the primary radical derived from i was trapped with TEMPO faster than it underwent 1,5-hydrogen atom transfer.
48. These modifications were developed during contemporaneous studies of the oxidation of an analogue of 12 having an isopropylidene substituent at C3.
49. The relative configuration of these products was determined by NOESY NMR experiments; see the Supporting Information for details.
50. 2 could be reduced to 7 equiv; however, yields of angular oxidation were maximized by using an equal excess of the silane.
51. 2S has been reported; see refs 4d, 4e, 4k, and 41.
52. More conventional conditions for removing the acetate group were not compatible with the disulfide bridge.
53. CCDC 663428. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
54. Larsen, C. H.; Ridgway, B. H.; Shaw, J. T.; Smith, D. M.; Woerpel, K. A. J. Am. Chem. Soc. 2005, 127, 10879-10884.